THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 95 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 28.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,000 | -50.0% | 57 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | +100.0% | 57 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | -50.0% | 57 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 57 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 57 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 11,213,879 | $254,331,000 | 30.84% |
| Cormorant Asset Management, LP | 1,300,000 | $29,484,000 | 2.18% |
| Baupost Group | 9,309,168 | $211,132,000 | 1.85% |
| SENZAR ASSET MANAGEMENT, LLC | 27,397 | $621,000 | 1.79% |
| ARMISTICE CAPITAL, LLC | 1,180,000 | $26,762,000 | 1.75% |
| Old West Investment Management, LLC | 111,101 | $2,519,000 | 1.27% |
| Chescapmanager LLC | 403,321 | $9,147,000 | 1.06% |
| Virtus ETF Advisers LLC | 30,055 | $682,000 | 0.60% |
| Rock Springs Capital Management LP | 652,600 | $14,801,000 | 0.57% |
| Foundation Asset Management, LP | 27,154 | $616,000 | 0.53% |